---
title: "Accumulating strength for a breakthrough, advancing with unstoppable momentum — Peijia Medical crosses the innovation threshold, entering a new stage of high-quality development"
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/42646030.md"
description: "On July 3, 2026, Peijia Medical Co., Ltd. (stock code: 9996.HK) held its annual corporate open day at its global headquarters in Suzhou. Under the theme "Accumulate Strength and Break Through," the company systematically showcased the development achievements of its two strategic segments—valve intervention therapy and neurointervention therapy—and shared key progress in R&D innovation, commercial operations, lean manufacturing, and global expansion. As the commercialization of its core products enters a period of intensive harvest, neurointervention business profitability expands, and internationalization steadily advances, Peijia Medical is accelerating onto the fast track of continuous innovation realization and high-quality development."
datetime: "2026-07-14T07:06:58.000Z"
locales:
  - [en](https://longbridge.com/en/topics/42646030.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/42646030.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/42646030.md)
author: "[所视sight](https://longbridge.com/en/profiles/26711722.md)"
---

# Accumulating strength for a breakthrough, advancing with unstoppable momentum — Peijia Medical crosses the innovation threshold, entering a new stage of high-quality development

On July 3, 2026, Peijia Medical Co., Ltd. (Stock Code: 9996.HK) held its annual corporate open day at its global headquarters in Suzhou. Under the theme "Accumulate Strength and Break Through," the company systematically showcased the development achievements of its two strategic sectors, valve intervention therapy and neurointervention therapy, and shared in-depth insights into key progress in R&D innovation, commercial operations, lean manufacturing, and global expansion. As the commercialization of its core products enters a period of intensive harvest, the profitability of its neurointervention business expands, and its internationalization efforts advance steadily, Peijia Medical is accelerating into the fast lane of continuous innovation realization and high-quality development.

### Related Stocks

- [09996.HK](https://longbridge.com/en/quote/09996.HK.md)
- [TRIO.US](https://longbridge.com/en/quote/TRIO.US.md)